The 2.4% residual t-cells aren’t useful if all the targeted cancers cells were destroyed and the surviving cancers cells have other mutations. Maybe they would prevent the targeted mutation from re-emerging but meantime the surviving
cancer cells would have caused fatal tumor progression. Seems obvious the t-cells must be programmed for multiple mutation antigens but that could be a few years away, earliest in 2024. Hunker down !